查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403411

臨床化學分析儀市場至2030年的預測：按產品、測試類型、模式、技術、應用、最終用戶和地區進行的全球分析

Clinical Chemistry Analyzers Market Forecasts to 2030 - Global Analysis By Product, Test Type, Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的資料，2023年全球臨床生化分析儀市場規模為141.7億美元，預計到2030年將達到172.6億美元，預測期內年複合成長率為6.2%。

臨床化學分析儀是一種先進的醫療設備，目的是分析血液、尿液和其他體液中的各種化學成分。這些自動化系統透過測量葡萄糖、膽固醇和酵素等物質的濃度，在疾病診斷和監測中發揮重要作用。其準確性和自動化提高了臨床環境中實驗室診斷的可靠性和速度。

根據加拿大癌症協會2021年報告，2021年加拿大將新增約229,200例癌症病例，平均每天有628名加拿大人診斷出罹患癌症。慢性病的增加刺激了北美地區臨床化學分析儀的成長。

慢性病增加

隨著糖尿病、心血管疾病和腎臟疾病等慢性疾病變得越來越普遍，對準確、及時的臨床化學分析的需求也隨之增加。臨床化學分析儀在這些疾病的監測和管理中發揮重要作用，並且在醫療保健環境中越來越普及。隨著醫療保健行業努力應對慢性病負擔日益增加的挑戰，這種趨勢可能會持續下去，促進市場的持續成長。

缺乏熟練人才

由於臨床化學分析的複雜性，需要經過培訓的專業人員來準確操作和解釋結果。這些儀器的複雜性要求人們對分析技術、測試協議和資料解釋有深入​​的了解。解決此技能差距對於充分發揮臨床化學分析儀的潛力非常重要，並可能阻礙普及和最佳功能。

轉向個人化醫療

個人化醫療根據個人特徵客製化醫療保健干預措施，以最佳化治療效果。臨床化學分析儀透過提供患者的詳細資料、實現準確的診斷和治療監測而發揮重要作用。隨著個體化醫療保健需求的增加，先進且適應性強的分析儀器的市場可能會擴大，為臨床化學領域的創新和成長開闢有希望的途徑。

營運和維護成本高

臨床化學分析儀由於其複雜的設計、先進的技術和嚴格的監管要求而導致較高的運作和維護成本。這些分析儀需要精確度和可靠性，需要複雜的組件和嚴格的品管。定期校準、維護和遵守不斷變化的標準會增加持續的費用。這些經濟挑戰阻礙了市場擴張。

COVID-19 的影響

COVID-19 的爆發對臨床化學分析儀市場產生了重大影響。對包括生化分析在內的診斷測試的需求不斷成長，是市場成長的驅動力。然而，供應鏈中斷，醫療機構預算削減和勞動力短缺帶來了挑戰。對快速、準確的測試解決方案的重視與技術的進步相結合，活性化了臨床化學分析儀領域的創新。市場表現出了彈性，適應不斷變化的醫療保健環境，並優先考慮滿足疫情引起的診斷需求的解決方案。

攜帶式分析儀細分市場預計將在預測期內成為最大的細分市場

由於能夠提供快速、準確的結果，攜帶式分析儀行業預計將出現良好的成長。攜帶式臨床化學分析儀是一種緊湊的診斷設備，可隨時隨地測量血液樣本的各種醫療參數。它目的是測量各種分析物，例如葡萄糖、膽固醇和電解質，可以快速診斷和監測各種醫療狀況。可移植性提高了診斷能力的獲取，特別是在資源有限和偏遠地區。

治療藥物監測（TDM）領域預計在預測期內年複合成長率最高

治療藥物監測（TDM）領域預計在預測期內年複合成長率最高。治療藥物監測（TDM）對於臨床化學分析儀非常重要，可確保患者獲得最佳藥物水準。這些分析儀測量生物樣本中的藥物濃度，並允許醫療保健專業人員根據個別患者的反應調整給藥方案。 TDM 可提高治療效果、最大限度地減少副作用並解決藥物代謝的變異性。

佔有率最大的地區

由於醫療基礎設施的增加，慢性病盛行率的上升以及對疾病早期發現的日益重視，預計亞太地區在預測期內將佔據最大的市場佔有率。亞太地區是Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Roche Diagnostics等大公司的所在地。該地區擁有強力的政府舉措和醫療機構發布的實踐指南的高實施率。此外，全球公司的高研發投資以及該地區開拓的機會推動高速成長。

年複合成長率最高的地區：

由於醫療保健技術的進步和慢性病的增加，預計北美在預測期內將呈現最高的年複合成長率。該地區擁有發達的醫療基礎設施，人口老化，對診斷服務的需求不斷增加，並推動了臨床化學分析儀市場的發展。產業主要企業致力於產品創新和策略聯盟以保持競爭力。此外，自動化系統和即時測試解決方案的採用也有助於市場擴張。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球臨床生化分析儀市場：依產品

  • 桌上型分析儀
  • 落地式分析儀
  • 攜帶式分析儀
  • 模組化分析儀
  • 綜合分析裝置
  • 其他產品

第6章 全球臨床生化分析儀市場：依測試類型

  • 基礎代謝組
  • 肝臟組
  • 電解質板
  • 血脂譜
  • 甲狀腺功能檢查
  • 腎功能檢查
  • 特殊面板

第7章 全球臨床生化分析儀市場：按模式

  • 全自動分析儀
  • 半自動分析儀
  • 照護端（POC）分析儀

第8章 全球臨床生化分析儀市場：依技術分類

  • 酵素測定技術
  • 離子選擇電極（ISE）技術
  • 比色技術
  • 化學冷光免疫檢測（CLIA）技術
  • 螢光技術
  • 電化學生物感測器
  • 分子診斷技術

第9章 全球臨床生化分析儀市場：依應用

  • 定期化學測試
  • 特殊化學測試
  • 治療藥物監測（TDM）
  • 在內分泌學上的應用
  • 心臟標記測試
  • 傳染病檢查
  • 其他用途

第10章 全球臨床化學分析儀市場：依最終用戶分類

  • 醫院
  • 診斷實驗室
  • 研究機構
  • 製藥和生物技術公司
  • 學術研究中心
  • 即時檢測（POCT）設施
  • 家庭醫療保健設置

第11章 全球臨床生化分析儀市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Abbott Laboratories
  • Mindray Medical International Limited
  • Siemens AG
  • F. Hoffmann-La Roche Limited
  • Danaher Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • HITACHI
  • Horiba Medical Limited
  • EKF Diagnostics
  • Roche Diagnostics
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories
  • Randox Laboratories
  • ELITechGroup
  • DiaSorin
  • Shimadzu Corporation
  • EDAN Instruments
Product Code: SMRC24636

According to Stratistics MRC, the Global Clinical Chemistry Analyzers Market is accounted for $14.17 billion in 2023 and is expected to reach $17.26 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Clinical Chemistry Analyzers are sophisticated medical instruments designed to analyze various chemical components in blood, urine, and other bodily fluids. These automated systems play a crucial role in diagnosing and monitoring diseases by measuring concentrations of substances like glucose, cholesterol, and enzymes. Their precision and automation enhance the reliability and speed of laboratory diagnostics in clinical settings.

According to the Canadian Cancer Society's 2021 report, about 229,200 new cancer cases will be diagnosed in Canada in 2021, and on average, 628 Canadians are diagnosed with cancer every day. The rising number of chronic diseases in the nation adds to the growth of clinical chemistry analyzers in the North American region.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The need for accurate and timely clinical chemistry analysis intensifies, as chronic conditions such as diabetes, cardiovascular diseases, and kidney disorders become more prevalent. Clinical chemistry analyzers play a crucial role in monitoring and managing these conditions, fostering their widespread adoption in healthcare settings. This trend is likely to persist, contributing to the market's sustained growth as the healthcare industry strives to address the challenges posed by the rising burden of chronic diseases.

Restraint:

Lack of skilled personnel

The complex nature of clinical chemistry analysis requires trained professionals for accurate operation and interpretation of results. The complexity of these instruments demands a workforce with a deep understanding of analytical techniques, laboratory protocols, and data interpretation. Addressing this skill gap becomes crucial for unlocking the full potential of clinical chemistry analyzers, potentially hindering their widespread adoption and optimal functionality in healthcare settings.

Opportunity:

Shift towards personalized medicine

Personalized medicine tailors healthcare interventions to individual characteristics, optimizing treatment efficacy. Clinical chemistry analyzers play a crucial role by providing detailed patient profiles, enabling precise diagnostics and treatment monitoring. As the demand for personalized healthcare rises, the market for advanced and adaptable analyzers is poised for expansion, creating a promising avenue for innovation and growth in the clinical chemistry sector.

Threat:

High operational costs & maintenance expenses

Clinical Chemistry Analyzers incur high operational costs and maintenance expenses due to their intricate design, sophisticated technology, and stringent regulatory requirements. These analyzers demand precision and reliability, necessitating complex components and rigorous quality control. Regular calibration, maintenance, and compliance with evolving standards contribute to ongoing expenses. These financial challenges collectively hamper the market expansion.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the Clinical Chemistry Analyzers market. The increased demand for diagnostic testing, including biochemical analysis, drove market growth. However, disruptions in the supply chain, reduced healthcare facility budgets, and workforce shortages posed challenges. The emphasis on rapid and accurate testing solutions, coupled with ongoing advancements in technology, stimulated innovation in the clinical chemistry analyzers sector. The market exhibited resilience, adapting to the evolving healthcare landscape and prioritizing solutions to address the diagnostic needs arising from the pandemic.

The portable analyzers segment is expected to be the largest during the forecast period

The portable analyzers segment is estimated to have a lucrative growth, due to their rapid and accurate results. Portable clinical chemistry analyzers are compact diagnostic devices that enable on-the-go testing of blood samples for various medical parameters. They are designed to measure a range of analytes, including glucose, cholesterol, and electrolytes, facilitating quick diagnosis and monitoring of various medical conditions. Their portability enhances accessibility to diagnostic capabilities, particularly in resource-limited or remote areas.

The therapeutic drug monitoring (TDM) segment is expected to have the highest CAGR during the forecast period

The therapeutic drug monitoring (TDM) segment is anticipated to witness the highest CAGR growth during the forecast period. Therapeutic Drug Monitoring (TDM) is crucial in Clinical Chemistry Analyzers to ensure optimal medication levels for patients. These analyzers measure drug concentrations in biological samples, enabling healthcare professionals to adjust dosage regimens based on individual patient responses. TDM enhances treatment efficacy, minimizes side effects, and addresses variability in drug metabolism which accelerates the segment growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on early disease detection. It also has the presence of major companies namely Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories and Roche Diagnostics. The supportive government initiatives and high implementation of practice guidelines released by healthcare organizations are present across this region. Furthermore, high R&D investment by the global players and presence of unexplored opportunities in this region serve as high growth rendering drivers.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, driven by advancements in healthcare technology and the increasing prevalence of chronic diseases. The region's well-established healthcare infrastructure, coupled with a rising aging population, has led to a higher demand for diagnostic services, boosting the market for clinical chemistry analyzers. Key players in the industry are focusing on product innovation and strategic collaborations to maintain a competitive edge. Further, the adoption of automated systems and point-of-care testing solutions is contributing to market expansion.

Key players in the market:

Some of the key players profiled in the Clinical Chemistry Analyzers Market include Abbott Laboratories, Mindray Medical International Limited, Siemens AG, F. Hoffmann-La Roche Limited, Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc., HITACHI, Horiba Medical Limited, EKF Diagnostics, Roche Diagnostics, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Randox Laboratories, ELITechGroup, DiaSorin, Shimadzu Corporation and EDAN Instruments.

Key Developments:

In May 2023, Siemens Healthineers launched the Atellica HEMA 570 and 580 Analyzers. These analyzers are designed for high-volume hematology testing. They are intended to streamline testing by integrating automation. The analyzers also have intuitive interfaces and multi-analyzer automation connectivity.

In July 2022, EDAN Instruments launched its POC fluorescence-based CO-OX blood gas and chemistry analysis system, i20, with the capacity to analyze over 45 parameters, covering everything from blood gases to electrolytes to CO-oximetry.

In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability.

Products Covered:

  • Benchtop Analyzers
  • Floor-standing Analyzers
  • Portable Analyzers
  • Modular Analyzers
  • Integrated Analyzers
  • Other Products

Test Types Covered:

  • Basic Metabolic Panels
  • Liver Panels
  • Electrolyte Panels
  • Lipid Profiles
  • Thyroid Function Panels
  • Renal Function Panels
  • Specialty Panels

Modalities Covered:

  • Fully Automated Analyzers
  • Semi-Automated Analyzers
  • Point-of-Care (POC) Analyzers

Technologies Covered:

  • Enzymatic Assay Technology
  • Ion-Selective Electrode (ISE) Technology
  • Colorimetric Technology
  • Chemiluminescence Immunoassay (CLIA) Technology
  • Fluorescence Technology
  • Electrochemical Biosensors
  • Molecular Diagnostics Technology

Applications Covered:

  • Routine Chemistry Testing
  • Special Chemistry Testing
  • Therapeutic Drug Monitoring (TDM)
  • Endocrinology Applications
  • Cardiac Markers Testing
  • Infectious Disease Testing
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Centers
  • Point-of-Care Testing (POCT) Facilities
  • Home Healthcare Settings

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Chemistry Analyzers Market, By Product

  • 5.1 Introduction
  • 5.2 Benchtop Analyzers
  • 5.3 Floor-standing Analyzers
  • 5.4 Portable Analyzers
  • 5.5 Modular Analyzers
  • 5.6 Integrated Analyzers
  • 5.7 Other Products

6 Global Clinical Chemistry Analyzers Market, By Test Type

  • 6.1 Introduction
  • 6.2 Basic Metabolic Panels
  • 6.3 Liver Panels
  • 6.4 Electrolyte Panels
  • 6.5 Lipid Profiles
  • 6.6 Thyroid Function Panels
  • 6.7 Renal Function Panels
  • 6.8 Specialty Panels

7 Global Clinical Chemistry Analyzers Market, By Modality

  • 7.1 Introduction
  • 7.2 Fully Automated Analyzers
  • 7.3 Semi-Automated Analyzers
  • 7.4 Point-of-Care (POC) Analyzers

8 Global Clinical Chemistry Analyzers Market, By Technology

  • 8.1 Introduction
  • 8.2 Enzymatic Assay Technology
  • 8.3 Ion-Selective Electrode (ISE) Technology
  • 8.4 Colorimetric Technology
  • 8.5 Chemiluminescence Immunoassay (CLIA) Technology
  • 8.6 Fluorescence Technology
  • 8.7 Electrochemical Biosensors
  • 8.8 Molecular Diagnostics Technology

9 Global Clinical Chemistry Analyzers Market, By Application

  • 9.1 Introduction
  • 9.2 Routine Chemistry Testing
  • 9.3 Special Chemistry Testing
  • 9.4 Therapeutic Drug Monitoring (TDM)
  • 9.5 Endocrinology Applications
  • 9.6 Cardiac Markers Testing
  • 9.7 Infectious Disease Testing
  • 9.8 Other Applications

10 Global Clinical Chemistry Analyzers Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Diagnostic Laboratories
  • 10.4 Research Institutes
  • 10.5 Pharmaceutical & Biotechnology Companies
  • 10.6 Academic Research Centers
  • 10.7 Point-of-Care Testing (POCT) Facilities
  • 10.8 Home Healthcare Settings

11 Global Clinical Chemistry Analyzers Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 Mindray Medical International Limited
  • 13.3 Siemens AG
  • 13.4 F. Hoffmann-La Roche Limited
  • 13.5 Danaher Corporation
  • 13.6 Sysmex Corporation
  • 13.7 Thermo Fisher Scientific Inc.
  • 13.8 HITACHI
  • 13.9 Horiba Medical Limited
  • 13.10 EKF Diagnostics
  • 13.11 Roche Diagnostics
  • 13.12 Ortho Clinical Diagnostics
  • 13.13 Bio-Rad Laboratories
  • 13.14 Randox Laboratories
  • 13.15 ELITechGroup
  • 13.16 DiaSorin
  • 13.17 Shimadzu Corporation
  • 13.18 EDAN Instruments

List of Tables

  • Table 1 Global Clinical Chemistry Analyzers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Chemistry Analyzers Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Clinical Chemistry Analyzers Market Outlook, By Benchtop Analyzers (2021-2030) ($MN)
  • Table 4 Global Clinical Chemistry Analyzers Market Outlook, By Floor-standing Analyzers (2021-2030) ($MN)
  • Table 5 Global Clinical Chemistry Analyzers Market Outlook, By Portable Analyzers (2021-2030) ($MN)
  • Table 6 Global Clinical Chemistry Analyzers Market Outlook, By Modular Analyzers (2021-2030) ($MN)
  • Table 7 Global Clinical Chemistry Analyzers Market Outlook, By Integrated Analyzers (2021-2030) ($MN)
  • Table 8 Global Clinical Chemistry Analyzers Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Clinical Chemistry Analyzers Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 10 Global Clinical Chemistry Analyzers Market Outlook, By Basic Metabolic Panels (2021-2030) ($MN)
  • Table 11 Global Clinical Chemistry Analyzers Market Outlook, By Liver Panels (2021-2030) ($MN)
  • Table 12 Global Clinical Chemistry Analyzers Market Outlook, By Electrolyte Panels (2021-2030) ($MN)
  • Table 13 Global Clinical Chemistry Analyzers Market Outlook, By Lipid Profiles (2021-2030) ($MN)
  • Table 14 Global Clinical Chemistry Analyzers Market Outlook, By Thyroid Function Panels (2021-2030) ($MN)
  • Table 15 Global Clinical Chemistry Analyzers Market Outlook, By Renal Function Panels (2021-2030) ($MN)
  • Table 16 Global Clinical Chemistry Analyzers Market Outlook, By Specialty Panels (2021-2030) ($MN)
  • Table 17 Global Clinical Chemistry Analyzers Market Outlook, By Modality (2021-2030) ($MN)
  • Table 18 Global Clinical Chemistry Analyzers Market Outlook, By Fully Automated Analyzers (2021-2030) ($MN)
  • Table 19 Global Clinical Chemistry Analyzers Market Outlook, By Semi-Automated Analyzers (2021-2030) ($MN)
  • Table 20 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care (POC) Analyzers (2021-2030) ($MN)
  • Table 21 Global Clinical Chemistry Analyzers Market Outlook, By Technology (2021-2030) ($MN)
  • Table 22 Global Clinical Chemistry Analyzers Market Outlook, By Enzymatic Assay Technology (2021-2030) ($MN)
  • Table 23 Global Clinical Chemistry Analyzers Market Outlook, By Ion-Selective Electrode (ISE) Technology (2021-2030) ($MN)
  • Table 24 Global Clinical Chemistry Analyzers Market Outlook, By Colorimetric Technology (2021-2030) ($MN)
  • Table 25 Global Clinical Chemistry Analyzers Market Outlook, By Chemiluminescence Immunoassay (CLIA) Technology (2021-2030) ($MN)
  • Table 26 Global Clinical Chemistry Analyzers Market Outlook, By Fluorescence Technology (2021-2030) ($MN)
  • Table 27 Global Clinical Chemistry Analyzers Market Outlook, By Electrochemical Biosensors (2021-2030) ($MN)
  • Table 28 Global Clinical Chemistry Analyzers Market Outlook, By Molecular Diagnostics Technology (2021-2030) ($MN)
  • Table 29 Global Clinical Chemistry Analyzers Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Global Clinical Chemistry Analyzers Market Outlook, By Routine Chemistry Testing (2021-2030) ($MN)
  • Table 31 Global Clinical Chemistry Analyzers Market Outlook, By Special Chemistry Testing (2021-2030) ($MN)
  • Table 32 Global Clinical Chemistry Analyzers Market Outlook, By Therapeutic Drug Monitoring (TDM) (2021-2030) ($MN)
  • Table 33 Global Clinical Chemistry Analyzers Market Outlook, By Endocrinology Applications (2021-2030) ($MN)
  • Table 34 Global Clinical Chemistry Analyzers Market Outlook, By Cardiac Markers Testing (2021-2030) ($MN)
  • Table 35 Global Clinical Chemistry Analyzers Market Outlook, By Infectious Disease Testing (2021-2030) ($MN)
  • Table 36 Global Clinical Chemistry Analyzers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 Global Clinical Chemistry Analyzers Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 Global Clinical Chemistry Analyzers Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 39 Global Clinical Chemistry Analyzers Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 40 Global Clinical Chemistry Analyzers Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 41 Global Clinical Chemistry Analyzers Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 42 Global Clinical Chemistry Analyzers Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 43 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care Testing (POCT) Facilities (2021-2030) ($MN)
  • Table 44 Global Clinical Chemistry Analyzers Market Outlook, By Home Healthcare Settings (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.